Bowel Cancer: Medical Treatments
Commons · Question 4573 · Tabled 29 May 2026 · Department of Health and Social Care · Official record
Answered 4 Jun 2026
Question
Asked by Daisy Cooper
To ask the Secretary of State for Health and Social Care, what assessment he has made of the equity of access to encorafenib with cetuximab treatments for bowel cancer between in England compared to (a) Scotland and (b) Wales.
Answer
Answered by Preet Kaur Gill, 4 Jun 2026
Department officials have not had any discussions with the Medicines and Healthcare products Regulatory Agency or the National Institute for Health and Care Excellence (NICE) about expediting the licensing and evaluation of the BREAKWATER treatment.The BR...